Key emerging themes for assessing the cost-effectiveness of reporting incidental findings

Affiliations

• ¹ Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), Philip R. Lee Institute for Health Policy; and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
• ² 1] School of Medicine, Stanford University, Sanford, California, USA [2] Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA.
• ³ 1] Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA [2] Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
• ⁴ 1] Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA [2] Department of Community Health Sciences, Cumming School of Medicine; O`Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
• ⁵ Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA.